Molecular tests for colorectal cancer screening

Clinical Colorectal Cancer

Volumn 10, Issue 1, 2011, Pages 8-23

  Bosch, Linda J W ^a   Carvalho, Beatriz ^a   Fijneman, Remond J A ^a   Jimenez, Connie R ^a   Pinedo, Herbert M ^a,b   Van Engeland, Manon ^c   Meijer, Gerrit A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Blood; DNA markers; FIT; FOBT; Protein markers; RNA; Stool

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA DEFENSIN; APC PROTEIN; ATM PROTEIN; CALGRANULIN; CLUSTERIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOOXYGENASE 2 INHIBITOR; GLUTATHIONE TRANSFERASE P1; HELICASE; K RAS PROTEIN; LACTOFERRIN; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA; MUCIN 1; ONCOSTATIN M RECEPTOR; PROTEIN MUTL; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR GATA 4; TUMOR MARKER; VIMENTIN; DNA; RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CARCINOGENESIS; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DNA METHYLATION; FUNCTIONAL PROTEOMICS; GENE MUTATION; HUMAN; LUNG CANCER; MICROSATELLITE INSTABILITY; OCCULT BLOOD TEST; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; COLORECTAL TUMOR; EARLY DIAGNOSIS; GENETIC MARKER; GENETICS; INSTRUMENTATION; METHODOLOGY; MUTATION; PATHOLOGY; PROTEOMICS; REVIEW; TIME;

COLORECTAL NEOPLASMS; DNA; DNA METHYLATION; EARLY DETECTION OF CANCER; GENETIC MARKERS; HUMANS; MUTATION; PROTEOMICS; RNA; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952693994     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.3816/CCC.2011.n.002     Document Type: Review

References (193)

1. A Jemal, R Siegel, E Ward et al. Cancer statistics, 2008 CA Cancer J Clin 58 2008 71 96 (Pubitemid 351521864)
2. S Jones, WD Chen, G Parmigiani et al. Comparative lesion sequencing provides insights into tumor evolution Proc Natl Acad Sci USA 105 2008 4283 4288 (Pubitemid 351754372)
3. JS Mandel, JH Bond, TR Church et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1993 1365 1371 (Pubitemid 23131388)
4. JS Mandel, TR Church, JH Bond et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 2000 1603 1607 (Pubitemid 32162983)
5. KJ Lee, M Inoue, T Otani et al. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan Cancer Detect Prev 31 2007 3 11 (Pubitemid 46367446)
6. FA Oort, JS Terhaar Sive Droste, RW Van Der Hulst et al. Colonoscopy controlled intra individual comparisons to screen relevant neoplasia - fecal immunochemical test versus guaiac based fecal occult blood test Aliment Pharmacol Ther 31 2009 432 439
7. LG Van Rossum, AF Van Rijn, M Van et al. Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests Neth J Med 67 2009 182 186
8. NK Osborn, DA Ahlquist Stool screening for colorectal cancer: molecular approaches Gastroenterology 128 2005 192 206 (Pubitemid 40039970)
9. G Lurje, M Schiesser, A Claudius et al. Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications J Oncol 2010 2010 392652
10. S Jahr, H Hentze, S Englisch et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665 (Pubitemid 34292602)
11. F Diehl, M Li, D Dressman et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors Proc Natl Acad Sci USA 102 2005 16368 16373 (Pubitemid 41688920)
12. BS Hong, JH Cho, H Kim et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells BMC Genomics 10 2009 556
13. DM Pegtel, K Cosmopoulos, DA Thorley-Lawson et al. Functional delivery of viral miRNAs via exosomes Proc Natl Acad Sci USA 107 2010 6328 6333
14. JM Garcia, V Garcia, C Pena et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched RNA 14 2008 1424 1432 (Pubitemid 351872198)
15. D Sidransky, T Tokino, SR Hamilton et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors Science 256 1992 102 105
16. R Deuter, O Muller Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR Hum Mutat 11 1998 84 89 (Pubitemid 128679154)
17. S Eguchi, N Kohara, K Komuta et al. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer Cancer 77 1996 1707 1710 (Pubitemid 26111856)
18. G Traverso, A Shuber, B Levin et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors N Engl J Med 346 2002 311 320 (Pubitemid 34438838)
19. SM Dong, G Traverso, C Johnson et al. Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 93 2001 858 865 (Pubitemid 32586613)
20. KA Boynton, IC Summerhayes, DA Ahlquist et al. DNA integrity as a potential marker for stool-based detection of colorectal cancer Clin Chem 49 2003 1058 1065 (Pubitemid 36751091)
21. DA Ahlquist, JE Skoletsky, KA Boynton et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 119 2000 1219 1227
22. KS Tagore, MJ Lawson, JA Yucaitis et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia Clin Colorectal Cancer 3 2003 47 53 (Pubitemid 37220787)
23. D Calistri, C Rengucci, R Bocchini et al. Fecal multiple molecular tests to detect colorectal cancer in stool Clin Gastroenterol Hepatol 1 2003 377 383 (Pubitemid 37248057)
24. RE Brand, ME Ross, AP Shuber Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection Am J Gastroenterol 99 2004 1338 1341 (Pubitemid 39062273)
25. DA Ahlquist, DJ Sargent, CL Loprinzi et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia Ann Intern Med 149 2008 441 450 W81
26. D Whitney, J Skoletsky, K Moore et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test J Mol Diagn 6 2004 386 395 (Pubitemid 39517408)
27. TF Imperiale, DF Ransohoff, SH Itzkowitz et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 351 2004 2704 2714 (Pubitemid 39665324)
28. J Olson, DH Whitney, K Durkee et al. DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests Diagn Mol Pathol 14 2005 183 191 (Pubitemid 41391802)
29. SH Itzkowitz, L Jandorf, R Brand et al. Improved fecal DNA test for colorectal cancer screening Clin Gastroenterol Hepatol 5 2007 111 117 (Pubitemid 46096834)
30. D Calistri, C Rengucci, A Lattuneddu et al. Detection of colorectal cancer by a quantitative fluorescence determination of DNA amplification in stool Neoplasia 6 2004 536 540 (Pubitemid 39411090)
31. D Calistri, C Rengucci, C Molinari et al. Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer Cell Oncol 31 2009 11 17
32. F Diehl, K Schmidt, KH Durkee et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients Gastroenterology 135 2008 489 498
33. KE Schuebel, W Chen, L Cope et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer PLoS Genet 3 2007 1709 1723 (Pubitemid 47510263)
34. S Derks, C Postma, PT Moerkerk et al. Promoter methylation precedes chromosomal alterations in colorectal cancer development Cell Oncol 28 2006 247 257 (Pubitemid 44950096)
35. HM Muller, M Oberwalder, H Fiegl et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363 2004 1283 1285 (Pubitemid 38496491)
36. K Lenhard, GT Bommer, S Asutay et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer Clin Gastroenterol Hepatol 3 2005 142 149 (Pubitemid 40220309)
37. WD Chen, ZJ Han, J Skoletsky et al. Detection in fecal DNA of colon cancer-specific methylation of the non expressed vimentin gene J Natl Cancer Inst 97 2005 1124 1132 (Pubitemid 41511211)
38. Z Huang, L Li, J Wang Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions Dig Dis Sci 52 2007 2287 2291 (Pubitemid 47246528)
39. W Zhang, M Bauer, RS Croner et al. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene Dis Colon Rectum 50 2007 1618 1626 (Pubitemid 47583343)
40. M Oberwalder, M Zitt, C Wontner et al. SFRP2 methylation in fecal DNA-a marker for colorectal polyps Int J Colorectal Dis 23 2008 15 19 (Pubitemid 350142355)
41. DR Wang, D Tang Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening World J Gastroenterol 14 2008 524 531 (Pubitemid 351320817)
42. SC Glockner, M Dhir, JM Yi et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Cancer Res 69 2009 4691 4699
43. DM Hellebrekers, MH Lentjes, SM Van den Bosch et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer Clin Cancer Res 15 2009 3990 3997
44. V Melotte, MH Lentjes, SM Van den Bosch et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J Natl Cancer Inst 101 2009 916 927
45. MS Kim, J Louwagie, B Carvalho et al. Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer PLoS ONE 4 2009 e6555
46. M Li, WD Chen, N Papadopoulos et al. Sensitive digital quantification of DNA methylation in clinical samples Nat Biotechnol 27 2009 858 863
47. C Ausch, YH Kim, KD Tsuchiya et al. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA Clin Chem 55 2009 1559 1563
48. WK Leung, KF To, EP Man et al. Detection of epigenetic changes in fecal DNA as a molecular screening test for colorectal cancer: a feasibility study Clin Chem 50 2004 2179 2182 (Pubitemid 39425867)
49. Z Petko, M Ghiassi, A Shuber et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps Clin Cancer Res 11 2005 1203 1209 (Pubitemid 40175772)
50. ZH Huang, LH Li, F Yang et al. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions World J Gastroenterol 13 2007 950 954 (Pubitemid 46470311)
51. WK Leung, KF To, EP Man et al. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps Am J Gastroenterol 102 2007 1070 1076 (Pubitemid 46698227)
52. YH Baek, E Chang, YJ Kim et al. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients Dis Colon Rectum 52 2009 1452 1459
53. T Nagasaka, N Tanaka, HM Cullings et al. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia J Natl Cancer Inst 101 2009 1244 1258
54. S Itzkowitz, R Brand, L Jandorf et al. A simplified, noninvasive stool DNA test for colorectal cancer detection Am J Gastroenterol 103 2008 2862 2870
55. YJ Yu, AP Majumdar, JM Nechvatal et al. Exfoliated cells in stool: a source for reverse transcription-PCR-based analysis of biomarkers of gastrointestinal cancer Cancer Epidemiol Biomarkers Prev 17 2008 455 458 (Pubitemid 351272800)
56. S Kanaoka, K Yoshida, N Miura et al. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening Gastroenterology 127 2004 422 427 (Pubitemid 39091890)
57. S Lagerholm, S Lagerholm, S Dutta et al. Non-invasive detection of c-myc p64, c-myc p67 and c-erbb-2 in colorectal cancer Scand J Gastroenterol 40 2005 1343 1350 (Pubitemid 41658734)
58. SJ Myung, SK Yang, HS Chang et al. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients J Gastroenterol Hepatol 20 2005 1578 1583
59. T Yamao, Y Matsumura, Y Shimada et al. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer Gastroenterology 114 1998 1196 1205 (Pubitemid 28243905)
60. CC Chien, SH Chen, CC Liu et al. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC) Transl Res 149 2007 96 102
61. T Takai, S Kanaoka, K Yoshida et al. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening Cancer Epidemiol Biomarkers Prev 18 2009 1888 1893
62. Y Koga, M Yasunaga, Y Moriya et al. Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis Cancer Sci 99 2008 1977 1983
63. FE Ahmed, P Vos, S Ijames et al. Transcriptomic molecular markers for screening human colon cancer in stool and tissue Cancer Genomics Proteomics 4 2007 1 20 (Pubitemid 46426643)
64. CC Chien, CC Chang, SH Yang et al. A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer Oncol Rep 15 2006 919 926
65. S Yajima, M Ishii, H Matsushita et al. Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer Int J Oncol 31 2007 1029 1037
66. A Damms, SC Bischoff Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases Int J Colorectal Dis 23 2008 985 992
67. Y Kim, S Lee, S Park et al. Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen Ann Clin Lab Sci 33 2003 32 38 (Pubitemid 36336997)
68. LF Brown, CG Fraser Effect of delay in sampling on haemoglobin determined by faecal immunochemical tests Ann Clin Biochem 45 2008 604 605
69. U Haug, MN Wente, CM Seiler et al. Tumor M2 pyruvate kinase as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening setting Clin Chem 52 2006 782 784
70. G Chung-Faye, B Hayee, S Maestranzi et al. Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation Inflamm Bowel Dis 13 2007 1374 1378 (Pubitemid 350206848)
71. U Haug, H Brenner New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness Int J Cancer 117 2005 169 176 (Pubitemid 41377434)
72. U Haug, S Hundt, H Brenner Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study Br J Cancer 99 2008 133 135 (Pubitemid 351920225)
73. PJ Limburg, DA Ahlquist, JA Gilbert et al. Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool Dig Dis Sci 45 2000 494 499 (Pubitemid 30171923)
74. DL Ouyang, JJ Chen, RH Getzenberg et al. Noninvasive testing for colorectal cancer: a review Am J Gastroenterol 100 2005 1393 1403 (Pubitemid 40904368)
75. YM Shastri, N Povse, O Schroder et al. Comparison of a novel fecal marker-fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study Clin Lab 54 2008 389 390
76. H Zou, JJ Harrington, A Sugumar et al. Detection of colorectal disease by stool defensin assay: an exploratory study Clin Gastroenterol Hepatol 5 2007 865 868 (Pubitemid 47031063)
77. S Pucci, E Bonanno, F Sesti et al. Clusterin in stool: a new biomarker for colon cancer screening? Am J Gastroenterol 104 2009 2807 2815
78. AG Roseth, J Kristinsson, MK Fagerhol et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28 1993 1073 1076 (Pubitemid 23350726)
79. AC von Roon, L Karamountzos, S Purkayastha et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy Am J Gastroenterol 102 2007 803 813 (Pubitemid 46496634)
80. PX Xing, GP Young, D Ho et al. A new approach to fecal occult blood testing based on the detection of haptoglobin Cancer 78 1996 48 56 (Pubitemid 26189904)
81. A Sieg, C Thoms, K Luthgens et al. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces Int J Colorectal Dis 14 1999 267 271 (Pubitemid 30085258)
82. IK Quaye Haptoglobin, inflammation and disease Trans R Soc Trop Med Hyg 102 2008 735 742
83. RJ Davies, A Freeman, LS Morris et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool Lancet 359 2002 1917 1919 (Pubitemid 34615772)
84. J Karl, N Wild, M Tacke et al. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers Clin Gastroenterol Hepatol 6 2008 1122 1128
85. S Hundt, U Haug, H Brenner Blood markers for early detection of colorectal cancer: a systematic review Cancer Epidemiol Biomarkers Prev 16 2007 1935 1953 (Pubitemid 47621167)
86. P Anker, F Lefort, V Vasioukhin et al. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer Gastroenterology 112 1997 1114 1120 (Pubitemid 27157521)
87. R Borchers, M Heinzlmann, R Zahn et al. K-ras mutations in sera of patients with colorectal neoplasias and long-standing inflammatory bowel disease Scand J Gastroenterol 37 2002 715 718 (Pubitemid 34620936)
88. JB de Kok, WW Van Solinge, TJ Ruers et al. Detection of tumour DNA in serum of colorectal cancer patients Scand J Clin Lab Invest 57 1997 601 604 (Pubitemid 27487931)
89. MS Kopreski, FA Benko, C Kwee et al. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer Br J Cancer 76 1997 1293 1299 (Pubitemid 27474970)
90. V Bazan, L Bruno, C Augello et al. Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study Ann Oncol 17 suppl 7 2006 vii84 vii90 (Pubitemid 43985187)
91. T Lecomte, A Berger, F Zinzindohoue et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis Int J Cancer 100 2002 542 548 (Pubitemid 34816154)
92. JY Wang, JS Hsieh, MY Chang et al. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers World J Surg 28 2004 721 726
93. R Grutzmann, B Molnar, C Pilarsky et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay PLoS ONE 3 2008 e3759
94. C Lofton-Day, F Model, T Devos et al. DNA methylation biomarkers for blood-based colorectal cancer screening Clin Chem 54 2008 414 423 (Pubitemid 351302625)
95. WK Leung, KF To, EP Man et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer Am J Gastroenterol 100 2005 2274 2279
96. BB Lee, EJ Lee, EH Jung et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer Clin Cancer Res 15 2009 6185 6191
97. J Louwagie, W Pommerien, G Brichard et al. A Plasma-based colorectal cancer (CRC) screening assay using DNA methylation markers- first results of multicenter studies Eur J Cance 7 2009 9
98. G Khair, JR Monson, J Greenman Epithelial molecular markers in the peripheral blood of patients with colorectal cancer Dis Colon Rectum 50 2007 1188 1203 (Pubitemid 47087460)
99. J Guo, B Xiao, X Zhang et al. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers J Mol Med 82 2004 768 774 (Pubitemid 40022271)
100. JE Hardingham, D Kotasek, B Farmer et al. Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction Cancer Res 53 1993 3455 3458 (Pubitemid 23229617)
101. R Douard, S Moutereau, V Serru et al. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients Clin Chem Lab Med 43 2005 127 132 (Pubitemid 40361457)
102. C Shen, L Hu, L Xia et al. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients Jpn J Clin Oncol 38 2008 770 776
103. JY Wang, CH Wu, CY Lu et al. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis World J Surg 30 2006 1007 1013
104. D Xu, XF Li, S Zheng et al. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients J Zhejiang Univ Sci B 7 2006 445 451
105. CS Yeh, JY Wang, CH Wu et al. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel Int J Oncol 28 2006 411 420
106. G Giribaldi, S Procida, D Ulliers et al. Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method J Mol Diagn 8 2006 105 112 (Pubitemid 43257441)
107. A Gradilone, P Gazzaniga, I Silvestri et al. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease Oncol Rep 10 2003 217 222
108. F Guadagni, J Kantor, S Aloe et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers Cancer Res 61 2001 2523 2532 (Pubitemid 32685833)
109. JM Silva, R Rodriguez, JM Garcia et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells Gut 50 2002 530 534 (Pubitemid 34638874)
110. FA Vlems, JH Diepstra, IM Cornelissen et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol Pathol 55 2002 156 163 (Pubitemid 34620765)
111. XW Zhang, HY Yang, P Fan et al. Detection of micrometastasis in peripheral blood by multi-sampling in patients with colorectal cancer World J Gastroenterol 11 2005 436 438 (Pubitemid 40125259)
112. A Castells, L Boix, X Bessa et al. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction Br J Cancer 78 1998 1368 1372 (Pubitemid 28495252)
113. N Dandachi, M Balic, S Stanzer et al. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients J Mol Diagn 7 2005 631 637 (Pubitemid 41601515)
114. P Huang, J Wang, Y Guo et al. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer J Cancer Res Clin Oncol 129 2003 192 198 (Pubitemid 36583700)
115. VV Lukyanchuk, H Friess, J Kleeff et al. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers Anticancer Res 23 2003 2711 2716 (Pubitemid 36897148)
116. MG Piva, F Navaglia, D Basso et al. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging Oncology 59 2000 323 328
117. R Douard, V Le Maire, P Wind et al. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients Surgery 129 2001 587 594 (Pubitemid 32374990)
118. A De Luca, S Pignata, A Casamassimi et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay Clin Cancer Res 6 2000 1439 1444 (Pubitemid 30226232)
119. TH Schiedeck, C Wellm, UJ Roblick et al. Diagnosis and monitoring of colorectal cancer by L6 blood serum polymerase chain reaction is superior to carcinoembryonic antigen-enzyme-linked immunosorbent assay Dis Colon Rectum 46 2003 818 825 (Pubitemid 36693403)
120. SM Lledo, E Garcia-Granero, F Dasi et al. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer Colorectal Dis 6 2004 236 242 (Pubitemid 38960850)
121. L Terrin, E Rampazzo, S Pucciarelli et al. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease Clin Cancer Res 14 2008 7444 7451
122. V Garcia, JM Garcia, C Pena et al. Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential Clin Cancer Res 12 2006 2095 2100
123. JM Garcia, C Pena, V Garcia et al. Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients Clin Cancer Res 13 2007 6351 6358 (Pubitemid 350075024)
124. C Shen, L Hu, L Xia et al. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR Clin Biochem 42 2009 194 200
125. SM Yie, B Lou, SR Ye et al. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse Ann Surg Oncol 15 2008 3073 3082
126. O Slaby, M Svoboda, J Michalek et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application Mol Cancer 8 2009 102
127. X Chen, Y Ba, L Ma et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases Cell Res 18 2008 997 1006
128. EK Ng, WW Chong, H Jin et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
129. Z Huang, D Huang, S Ni et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer Int J Cancer 127 2010 118 126
130. M Collado, V Garcia, JM Garcia et al. Genomic profiling of circulating plasma RNA for the analysis of cancer Clin Chem 53 2007 1860 1863 (Pubitemid 47509683)
131. P Findeisen, M Rockel, M Nees et al. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients Int J Oncol 33 2008 1001 1010
132. M Han, CT Liew, HW Zhang et al. Novel blood-based, five-gene biomarker set for the detection of colorectal cancer Clin Cancer Res 14 2008 455 460 (Pubitemid 351226113)
133. DA Smirnov, DR Zweitzig, BW Foulk et al. Global gene expression profiling of circulating tumor cells Cancer Res 65 2005 4993 4997 (Pubitemid 40827303)
134. DM Thomson, J Krupey, SO Freedman et al. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system Proc Natl Acad Sci USA 64 1969 161 167
135. E Tan, N Gouvas, RJ Nicholls et al. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer Surg Oncol 18 2009 15 24
136. OJ Cordero, D Ayude, M Nogueira et al. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer Br J Cancer 83 2000 1139 1146
137. C Melle, G Ernst, B Schimmel et al. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer Gastroenterology 129 2005 66 73 (Pubitemid 41002043)
138. N Saito, S Kameoka Serum laminin is an independent prognostic factor in colorectal cancer Int J Colorectal Dis 20 2005 238 244 (Pubitemid 40553002)
139. G Walgenbach-Brunagel, B Burger, ES Leman et al. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer J Cell Biochem 104 2008 286 294
140. ES Leman, RE Schoen, A Magheli et al. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer Clin Cancer Res 14 2008 1349 1354 (Pubitemid 351413914)
141. ET Waas, T Hendriks, RM Lomme et al. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients Dis Colon Rectum 48 2005 700 710 (Pubitemid 40880716)
142. HJ Nielsen, N Brunner, C Frederiksen et al. Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection Scand J Gastroenterol 43 2008 242 248 (Pubitemid 351161531)
143. M Thaysen-Andersen, IB Thogersen, U Lademann et al. Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1 Biochim Biophys Acta 1784 2008 455 463
144. YD Chen, S Zheng, JK Yu et al. [Application of serum protein pattern model in diagnosis of colorectal cancer] Zhonghua Zhong Liu Za Zhi 26 2004 417 420
145. DG Ward, N Suggett, Y Cheng et al. Identification of serum biomarkers for colon cancer by proteomic analysis Br J Cancer 94 2006 1898 1905 (Pubitemid 43882582)
146. ME de Noo, BJ Mertens, A Ozalp et al. Detection of colorectal cancer using MALDI-TOF serum protein profiling Eur J Cancer 42 2006 1068 1076
147. T Alexandrov, J Decker, B Mertens et al. Biomarker discovery in MALDI-TOF
148. Q Wang, J Shen, ZF Li et al. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer BMC Cancer 9 2009 287
149. DF Ransohoff, C Martin, WS Wiggins et al. Assessment of serum proteomics to detect large colon adenomas Cancer Epidemiol Biomarkers Prev 17 2008 2188 2193
150. Y Qiu, TH Patwa, L Xu et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot J Proteome Res 7 2008 1693 1703
151. HJ Kim, HJ Kang, H Lee et al. Identification of S100A8 and S100A9 as Serological Markers for Colorectal Cancer J Proteome Res 8 2009 1368 1379
152. Y Ma, J Peng, W Liu et al. Proteomic identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal carcinoma Mol Cell Proteomics 8 2009 1878 1890
153. M Roessler, W Rollinger, S Palme et al. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer Clin Cancer Res 11 2005 6550 6557 (Pubitemid 41338994)
154. M Roessler, W Rollinger, L Mantovani-Endl et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis Mol Cell Proteomics 5 2006 2092 2101 (Pubitemid 44817021)
155. CC Wu, HC Chen, SJ Chen et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes Proteomics 8 2008 316 332
156. Y Ran, H Hu, Z Zhou et al. Profiling tumor-associated autoantibodies for the detection of colon cancer Clin Cancer Res 14 2008 2696 2700
157. MJ Scanlan, YT Chen, B Williamson et al. Characterization of human colon cancer antigens recognized by autologous antibodies Int J Cancer 76 1998 652 658 (Pubitemid 28243936)
158. MJ Scanlan, S Welt, CM Gordon et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets Cancer Res 62 2002 4041 4047 (Pubitemid 34791072)
159. A Line, Z Slucka, A Stengrevics et al. Characterisation of tumour-associated antigens in colon cancer Cancer Immunol Immunother 51 2002 574 582 (Pubitemid 35232007)
160. M Reuschenbach, DM Von Knebel, N Wentzensen A systematic review of humoral immune responses against tumor antigens Cancer Immunol Immunother 58 2009 1535 1544
161. G Kijanka, S Hector, EW Kay et al. Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer Gut 59 2010 69 78
162. CC Chan, CW Fan, YB Kuo et al. Multiple serological biomarkers for colorectal cancer detection Int J Cancer 126 2010 1683 1690
163. I Babel, R Barderas, R Díaz-Uriarte et al. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays Mol Cell Proteomics 8 2009 2382 2395
164. LG Van Rossum, AF Van Rijn, MG Van Oijen et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening Int J Cancer 125 2009 746 750
165. A Vilkin, P Rozen, Z Levi et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test Am J Gastroenterol 100 2005 2519 2525
166. NB Tsui, EK Ng, YM Lo Stability of endogenous and added RNA in blood specimens, serum, and plasma Clin Chem 48 2002 1647 1653
167. S Clark, LD Youngman, A Palmer et al. Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies Int J Epidemiol 32 2003 125 130 (Pubitemid 36503488)
168. N Kutzner, I Hoffmann, C Linke et al. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test Cancer Lett 229 2005 33 41 (Pubitemid 41262537)
169. H Matsushita, Y Matsumura, Y Moriya et al. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis Gastroenterology 129 2005 1918 1927 (Pubitemid 41772969)
170. GP Young Population-based screening for colorectal cancer: Australian research and implementation J Gastroenterol Hepatol 24 suppl 3 2009 S33 S42
171. VW van, WP Mali [Colorectal cancer screening: advice from the Health Council of the Netherlands] Ned Tijdschr Geneeskd 153 2009 A1441
172. MJ Bourke Making every colonoscopy count: Ensuring quality in endoscopy J Gastroenterol Hepatol 24 Suppl 3 2009 S43 S50
173. M Parekh, AM Fendrick, U Ladabaum As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia Aliment Pharmacol Ther 27 2008 697 712 (Pubitemid 351406306)
174. S Richter Fecal DNA screening in colorectal cancer Can J Gastroenterol 22 2008 631 633
175. K Song, AM Fendrick, U Ladabaum Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis Gastroenterology 126 2004 1270 1279 (Pubitemid 38552791)
176. P Puig, E Urgell, G Capella et al. A highly sensitive method for K-ras mutation detection is useful in diagnosis of gastrointestinal cancer Int J Cancer 85 2000 73 77
177. G Traverso, A Shuber, L Olsson et al. Detection of proximal colorectal cancers through analysis of faecal DNA Lancet 359 2002 403 404 (Pubitemid 34158951)
178. J Wan, ZQ Zhang, WD You et al. Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance World J Gastroenterol 10 2004 743 746 (Pubitemid 38351550)
179. MR Abbaszadegan, A Tavasoli, A Velayati et al. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran World J Gastroenterol 13 2007 1528 1533 (Pubitemid 46672660)
180. S Onouchi, H Matsushita, Y Moriya et al. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces Anticancer Res 28 2008 145 150 (Pubitemid 351362894)
181. O Kronborg, M Ugstad, P Fuglerud et al. Faecal calprotectin levels in a high risk population for colorectal neoplasia Gut 46 2000 795 800 (Pubitemid 30329073)
182. B Johne, O Kronborg, HI Ton et al. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method Scand J Gastroenterol 36 2001 291 296 (Pubitemid 32234579)
183. J Tibble, G Sigthorsson, R Foster et al. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma Gut 49 2001 402 408 (Pubitemid 32802576)
184. J Kristinsson, K Nygaard, E Aadland et al. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II Digestion 64 2001 104 110 (Pubitemid 34701878)
185. KD Pant, JD McCracken Noninvasive colorectal cancer screening Dig Dis Sci 47 2002 1236 1240 (Pubitemid 34606625)
186. PJ Limburg, ME Devens, JJ Harrington et al. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia Am J Gastroenterol 98 2003 2299 2305 (Pubitemid 37305374)
187. M Mizuno, M Mizuno, N Iwagaki et al. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer Am J Gastroenterol 98 2003 2550 2555 (Pubitemid 37448770)
188. G Hoff, T Grotmol, E Thiis-Evensen et al. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT) Gut 53 2004 1329 1333 (Pubitemid 39120121)
189. PD Hardt, S Mazurek, M Toepler et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer Br J Cancer 91 2004 980 984 (Pubitemid 39273794)
190. M Yuan, X Xhang, Y Leu et al. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia Cancer Lett 235 2006 48 52
191. I Hirata, M Hoshimoto, O Saito et al. Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases World J Gastroenterol 13 2007 1569 1574 (Pubitemid 46672666)
192. SA Mulder, ME Van Leerdam, AJ Van Vuuren et al. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer Eur J Gastroenterol Hepatol 19 2007 878 882 (Pubitemid 47415147)
193. BC Yoo, YK Shin, SB Lim et al. Evaluation of calgranulin B in stools from the patients with colorectal cancer Dis Colon Rectum 51 2008 1703 1709